# Balaji Amines (NSE: BALAMINES) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/BALAMINES · Pivot · prices to 22 Oct 2026

Balaji Amines (NSE: BALAMINES) closed at ₹1,937.60 on 22 Oct 2026, down 0.07% on the day. With a market capitalisation of ₹6,278 Cr, it ranks 700th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Specialty Chemicals.

At its last close the stock traded at 37.6× trailing earnings, against a return on equity of 8.5% in FY26. Over the past year the share price has risen 43.6%. Its 52-week range is ₹968.10 (30 Mar 2026) to ₹2,629.80 (7 Sep 2026); the last close is 26.3% below the high. Promoters held 54.56% of the company as of 30 Jun 2026; 17.68% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹1,937.60 |
| Market cap | ₹6,278 Cr |
| P/E (trailing) | 37.6 |
| ROE | 8.5% (FY26) |
| ROCE | 10.2% (FY26) |
| Debt to equity | 0.07 |
| 52-week high | ₹2,629.80 (7 Sep 2026) |
| 52-week low | ₹968.10 (30 Mar 2026) |
| 1-year return | +43.6% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹1,397 Cr | ₹159 Cr |
| FY24 | ₹1,642 Cr | ₹232 Cr |
| FY23 | ₹2,355 Cr | ₹406 Cr |
| FY22 | ₹2,320 Cr | ₹418 Cr |
| FY21 | ₹1,311 Cr | ₹244 Cr |
| FY20 | ₹936 Cr | ₹97 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 54.56%
- Foreign institutions: 3.17%
- Domestic institutions: 1.59%
- Non-institutions: 40.69%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Clean Science and Technology](https://app.pivotnow.in/stock/CLEAN) | ₹719.25 | ₹7,644 Cr | 33.3 | — |
| [Neogen Chemicals](https://app.pivotnow.in/stock/NEOGEN) | ₹2,286.30 | ₹6,260 Cr | 211.1 | — |
| [Sharda Cropchem](https://app.pivotnow.in/stock/SHARDACROP) | ₹670.00 | ₹6,045 Cr | 8.9 | — |
| [Archean Chemical Industries](https://app.pivotnow.in/stock/ACI) | ₹462.75 | ₹5,713 Cr | 53.5 | — |
| [Gujarat State Fertilizers & Chemicals](https://app.pivotnow.in/stock/GSFC) | ₹140.32 | ₹5,591 Cr | 8.3 | — |
| [Rashtriya Chemicals and Fertilizers](https://app.pivotnow.in/stock/RCF) | ₹98.38 | ₹5,428 Cr | 12.7 | — |

## Questions and answers

### What is the share price of Balaji Amines today?

Balaji Amines (NSE: BALAMINES) last closed at ₹1,937.60 on 22 Oct 2026. Its 52-week high is ₹2,629.80 and its 52-week low is ₹968.10.

### What is the market cap of Balaji Amines?

Balaji Amines' market capitalisation is ₹6,278 Cr (₹6,278 Cr) at the 22 Oct 2026 close, ranking 700th among the NSE companies Pivot tracks.

### What is the P/E ratio of Balaji Amines?

Balaji Amines trades at a trailing P/E of 37.6. The median P/E of the 6 closest Chemicals peers by market cap is 33.3.

### What is the ROE and ROCE of Balaji Amines?

Return on equity was 8.5% in FY26 and return on capital employed was 10.2% in FY26 (consolidated figures).

### Is Balaji Amines a debt-free company?

No. Balaji Amines' debt-to-equity ratio was 0.07 in FY26, with total debt of ₹65 Cr.

### How has Balaji Amines stock performed over the last year?

Balaji Amines' share price has risen 43.6% over the past year, −18.9% over three months and −9.1% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Balaji Amines?

As of 30 Jun 2026: promoters 54.56%, foreign institutions 3.17%, domestic institutions 1.59%, non-institutions 40.69%. 17.68% of promoter shares were pledged.

### Who are Balaji Amines' competitors?

The listed Chemicals companies closest to Balaji Amines by market cap are Clean Science and Technology, Neogen Chemicals, Sharda Cropchem, Archean Chemical Industries, Gujarat State Fertilizers & Chemicals and Rashtriya Chemicals and Fertilizers.

### Is Balaji Amines a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Balaji Amines' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on BALAMINES against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.